This is a combined emdr.It was reported that the hand (grip) of the introducer came off when the ls cannula ((b)(6)) was percutaneously inserted and the introducer was removed.Ope will continue as is.Although there was some delay in the ope time, there was no particular impact.There were no effects on patients.No harm to any person was reported.This issue is known to manufacturer.A similar failure was investigated in a previous complaint. based on this, the complaint could be confirmed.The production history record (dhr) of the affected (b)(6) with lot# 3000277988 was reviewed.According to the dhr result, the product (b)(6) passed the defined manufacturing and final release specifications.There is no indication on manufacturing issues.The review of the non-conformities has been performed.It does not show any non-conformity in regards to the batch numbers of reported components and failure.Further the incoming inspection reports of the affected components griff (batch # 3000199908) and introducer (batch # 3000237282, 3000238222, 3000240088) were reviewed.The griff was checked visually for particles, pressure marks, rills, streaks, sinks, fat, dirt, blur, cords, scratches, burrs, bubbles and also measured for diameter (inner).The introducer was checked visually for ridges, sharp edges, cracks, streaks, dirt, spots, bubbles and also measured for diameter (outer).All tests were passed as per specifications.The reported failure was identified as part of the current risk management file and the most probable causes are associated to: 1.Manufacturing: - inappropriate assembly of components.2.Logistics: - mechanical damage of product due to vibration and impact during transport and storage.- loosening of handle from introducer due to vibration and impact during transport and storage.3.User: - loosening of handle from introducer during insertion of introducer into cannula due to mechanical loads.The occurrence rate was calculated for the reported failure and product and it was determined that this is not a systemic issue.Therefore, no remedial action is required.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonary¿s trending program and additional investigations or corrections will be implemented in case of adverse trending.
|